4NEURON aims to transform the lives of the 50 Mio. epilepsy patients. Superior anti-seizure efficacy is demonstrated in acute viable brain slices from multi-drug-resistant human epilepsy patients. Our innovative approach focuses on enhancing natural brain signaling with precision to target the disease’s underlying mechanisms. Combined with extremely reduced side effects compared to existing therapies, this brings un­precedented potential to epilepsy management. With strong scientific validation and a significant market opportunity, we seek strategic partnerships for accelerated development and commercialization to meet patients’ needs.